BCMA induces the PI3/AKT, MAPK, and NF-κB signaling cascades by binding with its ligands, a proliferation-inducing ligand (APRIL) and B-cell activating factor (BAFF), promoting tumor cell proliferation and survival [36, 37]. This evidence concerns the gene TNFSF13B and neoplasm.